Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hoffer

Showing results (441-450 of 496) with videos related to

Pageof 50
Sort By:
Scientific Reports|July 18, 2018
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Cell Transplantation|September 9, 2014
Dopamine Release Impairment in Striatum After Different Levels of Cerebral Cortical Fluid Percussion InjuryYuan-Hao Chen, Eagle Yi-Kung Huang, Tung-Tai Kuo, et al.
International Journal of Molecular Sciences|August 7, 2021
3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain InjuryPen-Sen Huang, Ping-Yen Tsai, Ling-Yu Yang, et al.
Scientific Reports|September 14, 2018
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Genomics|April 1, 1989
Nucleotide sequence comparison of five human pepsinogen A (PGA) genes: evolution of the PGA multigene familyM P Evers, B Zelle, J P Bebelman, et al.
Experimental Neurology|September 28, 2011
A mouse model of blast-induced mild traumatic brain injuryVardit Rubovitch, Meital Ten-Bosch, Ofer Zohar, et al.
Nature|March 21, 1996
Functional recovery in parkinsonian monkeys treated with GDNFD M Gash, Z Zhang, A Ovadia, et al.
Cells|July 6, 2023
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary MicrogliaElliot J Glotfelty, Luis B Tovar-Y-Romo, Shih-Chang Hsueh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2015
Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratioJaime M Ross, Johanna Öberg, Stefan Brené, et al.
Pageof 50

Showing results (441-450 of 496) with videos related to

Sort By:
Pageof 50
Scientific Reports|July 18, 2018
Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Cell Transplantation|September 9, 2014
Dopamine Release Impairment in Striatum After Different Levels of Cerebral Cortical Fluid Percussion InjuryYuan-Hao Chen, Eagle Yi-Kung Huang, Tung-Tai Kuo, et al.
International Journal of Molecular Sciences|August 7, 2021
3,6'-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain InjuryPen-Sen Huang, Ping-Yen Tsai, Ling-Yu Yang, et al.
Scientific Reports|September 14, 2018
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's diseaseShuchun Chen, Seong-Jin Yu, Yazhou Li, et al.
Genomics|April 1, 1989
Nucleotide sequence comparison of five human pepsinogen A (PGA) genes: evolution of the PGA multigene familyM P Evers, B Zelle, J P Bebelman, et al.
Experimental Neurology|September 28, 2011
A mouse model of blast-induced mild traumatic brain injuryVardit Rubovitch, Meital Ten-Bosch, Ofer Zohar, et al.
Nature|March 21, 1996
Functional recovery in parkinsonian monkeys treated with GDNFD M Gash, Z Zhang, A Ovadia, et al.
Cells|July 6, 2023
The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary MicrogliaElliot J Glotfelty, Luis B Tovar-Y-Romo, Shih-Chang Hsueh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 2, 2015
Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratioJaime M Ross, Johanna Öberg, Stefan Brené, et al.
Pageof 50